S 2328 · 108th Congress 2003–2005, ended

Pharmaceutical Market Access and Drug Safety Act of 2004

Latest action · Jul 14, 2004 Committee on the Judiciary. Hearings held.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedApr 21, 2004
  2. Passed SenateNot reached
  3. Passed HouseNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Pharmaceutical Market Access and Drug Safety Act of 2004 - Amends the Federal Food, Drug, and Cosmetic Act to revise provisions governing the importation of prescription drugs. Requires the Secretary of Health and Human Services to promulgate regulations allowing the importation of prescription drugs by registered exporters or registered importers from Canada within 90 days of passage of this Act and from Australia, European Union countries, Japan, New Zealand, or Switzerland within one year.

Provides for inspection, tracking of drugs, and registration and inspection fees for registered importers and exporters.

Requires manufacturers to: (1) submit a statement to the Secretary explaining each difference between a drug approved and distributed in the United States and a related drug distributed in a foreign country; and (2) submit an application to the Food and Drug Administration (FDA) for approval of a related drug that is distributed in a foreign country if there is no comparable drug already approved in at least half of the permitted countries that can be imported to the United States.

Allows for the immediate importation of prescription drugs for personal use from licensed Canadian pharmacies.

Amends the Clayton Act to prohibit drug manufacturers from preventing importation by engaging in behavior such as charging higher prices or limiting supplies to registered exporters and importers or changing the form of the drug for such purpose.

States that the resale in the United States of prescription drugs that were properly sold abroad is not patent infringement.

Requires the Secretary of Homeland Security to refuse admission of drugs that violate importation provisions. Allows the destruction of certain violative shipments.

Amends the Controlled Substances Act to repeal the exemption that permitted individuals to import controlled substances for personal medical use.

Cosponsors 31

Members who signed on, in the order they did. Signatures ran from Apr 21, 2004 to Sep 10, 2004; 10 are original cosponsors, there from the day it was introduced.

SeatCosponsorSigned on
D-MIDebbie StabenowOriginalApr 21, 2004
D-MAEdward M. KennedyOriginalApr 21, 2004
R-AZJohn McCainOriginalApr 21, 2004
R-RILincoln ChafeeOriginalApr 21, 2004
D-ARMark L. PryorOriginalApr 21, 2004
R-MEOlympia J. SnoweOriginalApr 21, 2004
D-WIRussell D. FeingoldOriginalApr 21, 2004
D-SDThomas A. DaschleOriginalApr 21, 2004
D-SDTim JohnsonOriginalApr 21, 2004
R-MSTrent LottOriginalApr 21, 2004
D-FLBill NelsonApr 22, 2004
D-NYCharles E. SchumerApr 22, 2004
D-CADianne FeinsteinApr 22, 2004
D-MNMark DaytonApr 22, 2004
D-MAJohn F. KerryApr 26, 2004

Committees 2

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
SenateHealth, Education, Labor, and Pensions Committee
Referred Apr 21, 2004Hearings May 20, 2004
SenateJudiciary Committee
Hearings Jul 14, 2004

Actions 5

Everything that happened, newest first.

  1. Jul 14, 2004Committee on the Judiciary. Hearings held.
  2. May 20, 2004Committee on Health, Education, Labor, and Pensions. Hearings held. Hearings printed: S.Hrg. 108-470.
  3. Apr 21, 2004Introduced in Senate
  4. Apr 21, 2004Sponsor introductory remarks on measure. (CR S4227-4228)
  5. Apr 21, 2004Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

In the Congressional Record 6

Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.

WhereIn the RecordMembersDate
SenateDebate and remarks S10411, S10412Byron L. Dorgan D-NDOct 5, 2004
SenateDebate and remarks S9072Christopher J. Dodd D-CTSep 10, 2004
SenateDebate and remarks S8932Byron L. Dorgan D-NDSep 8, 2004
ExtensionsDebate and remarks E1516Bob Filner D-CAJul 22, 2004
SenateDebate and remarks S8498Debbie Stabenow D-MIJul 21, 2004

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Printed hearings 2

Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.

NumberHearingCommitteeHeld
S. Hrg. 108-923EXAMINING THE IMPLICATIONS OF DRUG IMPORTATION282 pagesJudiciary CommitteeJul 14, 2004
S. Hrg. 108-470IMPORTATION OF PRESCRIPTION DRUGS129 pagesHealth, Education, Labor, and Pensions CommitteeMay 20, 2004

CRS reports 1

Congressional Research Service work that CRS links to this bill or the law it became, newest first.

Cite it 1

Products on other subjects that cite it, usually among other measures.

ProductTitleKindPublished
R44640Patents and Prescription Drug Importation ArchivedReportOct 4, 2016

Titles 3

Every title it has carried, official and short, at each stage.

Official Title as Introduced
A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes.
Short Titles as Introduced
Pharmaceutical Market Access and Drug Safety Act of 2004
Popular Titles
Imports of Prescription Drugs bill

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Apr 21, 2004Introduced in Senate

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.